Moderna Innovation and Technology Centre
Moderna’s Innovation and Technology Centre at Harwell combines UK vaccine manufacturing with research and clinical development.[1]
Current position
The facility opened with a manufacturing licence for UK-made mRNA COVID-19 vaccines and NHS supply.
Benefits
- Capacity for up to 100 million vaccine doses a year, with potential surge capacity of 250 million during a pandemic.